Fondazione Policlinico Gemelli IRCCS
Roma 00168
1 studies enrolling now · 3 studies all time
What they study most
Alzheimer's Disease, Metastatic Uveal Melanoma, Parkinson Disease
Studies at this site
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease — Recruiting now
- IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma — Running, not enrolling
- A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia — Completed